# Inhibikase Therapeutics, Inc. (IKT)

Inhibikase Therapeutics (IKT) sees a surge in social media interest with engagements up significantly, despite a recent price dip. This heightened social activity suggests potential market correction or temporary fluctuation amidst growing online attention.

### About Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. is a biotechnology company focused on developing novel therapeutics.  
Inhibikase Therapeutics, Inc. uses the ticker $IKT for trading. Listed in the [Stocks](/list/stocks) category.

### Insights
- Inhibikase Therapeutics, Inc. (IKT) social dominance is up 316.67% from the previous [--] months.
- Inhibikase Therapeutics, Inc. (IKT) Galaxy Score™ is up 25% from the previous week.
- Inhibikase Therapeutics, Inc. (IKT) mentions is up 2136.36% from the previous month.

### Price: $1.70
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$ikt/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$ikt/time-series/close.tsv)  
Despite a recent price decrease of -3.33% in the last [--] hours, social media metrics for Inhibikase Therapeutics (IKT) show a significant increase in engagements, mentions, and creators, suggesting the current price action may be a market correction or a temporary dip amidst heightened social interest.  

24-Hour: 0.61%
7-Day: -3.47%

1-Year High: $2.10 on 2025-12-31  
1-Year Low: $1.40 on 2025-12-02  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$ikt/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$ikt/time-series/alt_rank.tsv)  
Inhibikase Therapeutics, Inc. (IKT) is currently AltRank #2,266 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +2,080  
1-Year High: [-----] on 2026-02-11  
1-Year Low: [---] on 2026-01-24  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$ikt/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$ikt/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +7  
[--] Month: [--] [---]  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2026-01-30  
1-Year Low: [--] on 2025-04-09  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ikt/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ikt/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [-----]  
[--] Week: [-----] -67%  
[--] Month: [------] -62%  
[--] Months: [-------] +35%  
[--] Year: [-------] -58%  
1-Year High: [------] on 2025-08-22  
1-Year Low: [--] on 2025-04-10  

Engagements by network (24h):
Reddit: [--]
News: [--]
X: [---]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ikt/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ikt/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] +13%  
[--] Month: [---] +2,136%  
1-Year High: [---] on 2025-06-30  
1-Year Low: [--] on 2025-04-10  

Mentions by network (24h):
Reddit: [--]
News: [--]
X: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ikt/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ikt/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Inhibikase Therapeutics, Inc. (IKT) in the last [--] hours which is up 40% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] +9.30%  
[--] Month: [---] +2,167%  
1-Year High: [---] on 2025-06-30  
1-Year Low: [--] on 2025-04-10  

The most influential creators that mention Inhibikase Therapeutics, Inc. in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@plainyogurt21](/creator/twitter/plainyogurt21)     | [--]    | [-------]   | [--]     | [---]         |
| [@ayasalmny](/creator/twitter/ayasalmny)             | [--]    | [--]        | [--]     | [---]         |
| [@rynltmymy873300](/creator/twitter/rynltmymy873300) | [--]    | [--]        | [--]     | [---]         |
| [@jsm1sa](/creator/twitter/jsm1sa)                   | [--]    | [---]       | [--]     | [--]          |
| [@Bionavgator](/creator/twitter/Bionavgator)         | [--]    | [---]       | [--]     | [--]          |
| [@sujoy48883](/creator/twitter/sujoy48883)           | [--]    | [--]         | [--]     | [--]           |

[View More](/list/creators/$ikt/100)
  
  
### Sentiment: 100%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ikt/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ikt/time-series/sentiment.tsv)  
Current Value: 100%  
Daily Average: 85%  
[--] Week: 100% no change  
[--] Month: 100% +11%  
[--] Months: 100% +25%  
[--] Year: 100% +67%  
1-Year High: 100% on 2025-02-15  
1-Year Low: 25% on 2025-03-10  

Most Supportive Themes:
- $IKT Engagements: (196%) The engagements for $IKT have seen a significant surge, reaching [----].
  
Most Critical Themes:
  
  
  
### Social Dominance: 0.00178%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ikt/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$ikt/time-series/social_dominance.tsv)  
Current Value: 0.00178%  
Daily Average: 0.00263%  
[--] Week: 0.0047% +0.0024%  
[--] Month: 0.0025% +0.0009%  
[--] Months: 0.0025% -0.0002000000000000001%  
[--] Year: 0.0025% -0.0016%  
1-Year High: 0.032% on 2025-06-30  
1-Year Low: 0.0001% on 2025-09-12  
  
  
### Market Dominance: 0.00022934113235198656%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ikt/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$ikt/time-series/market_dominance.tsv)  
Current Value: 0.00022934113235198656%  
Daily Average: 0%  
1-Year High: 0.00952% on 2026-02-06  
1-Year Low: 0.00023% on 2026-02-14  
  
  
### Market Cap: $202,515,965
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$ikt/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$ikt/time-series/market_cap.tsv)  
Current Value: $202,515,965  
Daily Average: $200,127,372  
[--] Week: $200,090,624 -4.60%  
[--] Month: $202,515,965 +1.20%  
1-Year High: $218,280,681 on 2026-01-22  
1-Year Low: $181,900,568 on 2026-01-30  

### Top Inhibikase Therapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"👇  : $SXTC $BCDA $GLDG $BTM $MIRA $IKT $SHPH $JDZG $SBFM $VBIX $SOBR $XTIA $MGIH $GRWG $YAAS #_ http://t.me/Tawsiiatfalcon1 http://t.me/Tawsiiatfalcon1"  
[X Link](https://x.com/ayasalmny/status/2022010760470364191) [@ayasalmny](/creator/x/ayasalmny) 2026-02-12T18:11Z [--] followers, [---] engagements


"IMO if there's a dagger in the heart of the $GOSS thesis it's that pbo-crossovers didn't do anything btwn 24-48mo. That said I still think it was way too cheap 1.5yr ago at $0.60 ($150M FD) based on data/upside and had to runup. That's essentially my thesis on $IKT today"  
[X Link](https://x.com/Vulpescap/status/2019473797024248223) [@Vulpescap](/creator/x/Vulpescap) 2026-02-05T18:10Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing